Literature DB >> 10400825

Role of interleukin-6 in a non-septic shock model induced by zymosan.

S Cuzzocrea1, G de Sarro, G Costantino, E Mazzon, R Laurà, E Ciriaco, A de Sarro, A P Caputi.   

Abstract

In the present study, we used IL-6 knock-out mice (IL-6KO) to evaluate a possible role of IL-6 in the pathogenesis of non-septic shock induced by peritoneal injection of zymosan. A severe inflammatory response characterized by peritoneal exudation, high peritoneal levels of nitrate/nitrite, and leukocyte infiltration into peritoneal exudate was induced by zymosan administration in wild-type control (WT) mice. This inflammatory process coincided with the damage to the lung and small intestine, as assessed by histological examination. Lung, small intestine and liver myeloperoxidase (MPO) activity, indicative of neutrophil infiltration and lipid peroxidation, were significantly increased in zymosan-treated WT mice. Peritoneal administration of zymosan in the WT mice also induced a significant increase in the plasma levels of nitrite/nitrate and in the levels of peroxynitrite, 18 hours after zymosan challenge. Immunohistochemical examination demonstrated a marked increase in the immunoreactivity to nitrotyrosine in the lung of zymosan-treated WT mice. Zymosan-treated IL-6KO showed significantly decreased mortality and inhibition of the development of peritonitis. In addition, IL-6KO mice showed significant protection from the development of organ failure, since tissue injury and MPO was reduced in the lung, small intestine and liver. Furthermore, a significant reduction of suppression of mitochondrial respiration, DNA strand breakage and reduction of cellular levels of NAD+ was observed in ex vivo macrophages harvested from the peritoneal cavity of IL-6KO mice subjected to zymosan-induced non-septic shock. In vivo treatment with anti-IL-6 (5,000 ng/day per mouse, 24 and 1 hour before zymosan administration) significantly reduced the inflammatory process. Taken together, the present study clearly demonstrates that IL-6 exerts a role in zymosan-induced non-septic shock.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400825

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  13 in total

1.  Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures.

Authors:  Barbara Rinaldi; Salvatore Cuzzocrea; Maria Donniacuo; Annalisa Capuano; Donatella Di Palma; Francesco Imperatore; Emanuela Mazzon; Rosanna Di Paola; Loredana Sodano; Francesco Rossi
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

2.  The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock.

Authors:  Stefania Marzocco; Rosanna Di Paola; Emanuela Mazzon; Tiziana Genovese; Domenico Britti; Aldo Pinto; Giuseppina Autore; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2005-03-15       Impact factor: 17.440

3.  Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.

Authors:  Salvatore Cuzzocrea; Antonietta Rossi; Ivana Serraino; Rosanna Di Paola; Laura Dugo; Tiziana Genovese; Domenico Britti; Giuseppe Sciarra; Angelina De Sarro; Achille P Caputi; Lidia Sautebin
Journal:  Intensive Care Med       Date:  2004-07-06       Impact factor: 17.440

4.  Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.

Authors:  Maria Galuppo; Rosanna Di Paola; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Irene Paterniti; Elisabetta Cuzzocrea; Placido Bramanti; Amar Kapoor; Christoph Thiemermann; Salvatore Cuzzocrea
Journal:  J Inflamm (Lond)       Date:  2010-02-18       Impact factor: 4.981

5.  Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.

Authors:  Seyhan Sahan-Firat; Meryem Temiz-Resitoglu; Demet Sinem Guden; Sefika Pinar Kucukkavruk; Bahar Tunctan; Ayse Nihal Sari; Zumrut Kocak; Kafait U Malik
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

6.  A Pro-resolving Role for Galectin-1 in Acute Inflammation.

Authors:  Hannah L Law; Rachael D Wright; Asif J Iqbal; Lucy V Norling; Dianne Cooper
Journal:  Front Pharmacol       Date:  2020-03-20       Impact factor: 5.810

7.  Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.

Authors:  Salvatore Cuzzocrea; Antonietta Rossi; Barbara Pisano; Rosanna Di Paola; Tiziana Genovese; Nimesh S A Patel; Elisabetta Cuzzocrea; Angela Ianaro; Lidia Sautebin; Francesco Fulia; Prabal K Chatterjee; Achille P Caputi; Christoph Thiemermann
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

8.  Tissue- and time-dependent upregulation of cytokine mRNA in a murine model for the multiple organ dysfunction syndrome.

Authors:  Thomas J H Volman; R Jan A Goris; Jos W M van der Meer; Thijs Hendriks
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

9.  Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury.

Authors:  Dung Hoang Nguyen; Newton Cho; Kajana Satkunendrarajah; James W Austin; Jian Wang; Michael G Fehlings
Journal:  J Neuroinflammation       Date:  2012-09-21       Impact factor: 8.322

10.  Kinetics of proinflammatory cytokines after intraperitoneal injection of tribromoethanol and a tribromoethanol/xylazine combination in ICR mice.

Authors:  Yoon Ju Cho; Young Ah Lee; Jae Won Lee; Jong In Kim; Jin Soo Han
Journal:  Lab Anim Res       Date:  2011-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.